tirzepatide loss of exclusivity Semaglutide & Patent Considerations Tirzepatide for Medical Weight Loss

GLP-1 medications may reduce the risk of heart disease

FDA approves Novo Nordisks new Wegovy HD injection, delivering the highest weight loss to date for a Wegovy injection, adding to its already expansive clinical profile

For instance, a retrospective observational study on hospitalized elderly patients with type 2 diabetes found that patients treated with GLP-1 receptor agonists combined with basal insulin had an increase in limb skeletal muscle mass, while those treated only with basal insulin showed a slight decrease, suggesting that under specific clinical management conditions, GLP-1 receptor agonists may help maintain muscle mass [61]

If possible, plan to enjoy pizza later in your dosing week when symptoms may be milder